-
DiscoveryRare speed on a rare disease
An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.
Discovery -
DiscoveryStepping toward regenerative medicine for diabetes
Discovery points toward treatment options beyond insulin injections
Discovery -
DiscoveryCompounds spur insulin-producing cells to replicate in the lab
Discovery -
DiscoveryClinical trials make a move toward mice
By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs
Discovery -
DiscoveryGetting down to the roots of Alzheimer’s disease
Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.
Discovery -
DiscoveryStopping Alzheimer's disease before it starts
Novartis collaborates with the Banner Alzheimer’s Institute to test treatments for preventing Alzheimer’s disease.
Discovery -
DiscoveryNovartis cancer researchers advance precision medicine
Learn how NIBR uses next generation sequencing to transform clinical trials and diagnostics in oncology.
Discovery -
DiscoveryTurning research advances into innovative medicines
A strong background in biological research prepared Daniel Rooks for his role in shaping the early clinical development of new medicines
Discovery -
DiscoveryRewriting the playbook for clinical testing in a rare disease
A Novartis team blazes new trails with an experimental treatment for spinal muscular atrophy.
Discovery -
DiscoveryCould umbilical cords yield more stem cells for life-saving transplants?
Umbilical cords are a potentially life-saving source of blood stem cells for people with leukemia and other diseases. But there aren’t enough cells to meet demand. Now an experimental treatment offers hope for a solution.
Discovery -
DiscoveryHow a love of sport led to a scientific breakthrough
Jeff Weers’ passion inspired a new way of getting inhaled medicine past the body’s natural defenses to reach the lungs.
Discovery -
DiscoveryNew recruit has big dreams for cancer immunotherapy
Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.
Discovery